Nanalyze
Nanalyze
✓

Gene Editing Updates - CRISPR, Intellia, and Beam

00:13:01
Podcasts
RSS
Link

OM DENNE EPISODE

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/rp9e1V8dfPk.

We revisit gene editing stocks once per year because things move very slowly in this space. While there may be upwards of 27 gene editing stocks out there, our focus is on the three biggest – Beam Therapeutics BEAM, Intellia Therapeutics NTLA, and CRISPR Therapeutics CRSP. Each of these companies is racing to bring treatments to market using their respective gene editing technologies. Of these three gene editing companies, CRISPR seems to be the furthest ahead as they await regulatory approval - in the USA and UK/Europe - for the first gene editing enabled therapy, exa-cel. These updates on gene editing stocks provide investors with the latest news on the biggest players.

Forretning
Investering
Engelsk
USA
BrugAPItil å hente denne episode iJSON

I DENNE EPISODE

Redigér disse tags

UDSKRIFT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SØK BLANT TIDLIGERE EPISODER

Søk etter gamle episoder av Nanalyze.
Integrer denne søgefelt på ditt nettsted

ANDRE EPISODE I DENNE PODKAST

The Nanalyze Verdict: Kazakhstan's Amazon

The Nanalyze Verdict: Kazakhstan's Amazon

Kaspi stock is an investment in the market-leading "superapp" in Kazakhstan. Most of the country uses Kaspi to make payments, go shopping, and process transactions. It's also the only Kazakh stock to trade on a U.S. stock exchange under the ticker $KSPI. Kaspi stock sports a low valuation…
00:13:45
DEL
LAGRE
The Nanalyze Verdict: Apple Stock

The Nanalyze Verdict: Apple Stock

Apple is the most well-known brand in the world. The company is worth nearly $5 trillion. Apple leads the smartphone market. They're expanding their AI solutions. They have a new CEO. But, is $AAPL stock a buy now? In this video, we'll look at Apple stock objectively to see why you might - or might…
00:10:43
DEL
LAGRE
Once You Understand This, You'll Avoid Covered Call ETFs

Once You Understand This, You'll Avoid Covered Call ETFs

Covered call ETFs like $JEPI are weapons of wealth destruction. It's not that they're inherently evil, they just aren't a good investment option for the vast majority of people. They're proven to underperform over long time frames, they're tax inefficient, and there are better ways to get income. B…
00:14:03
DEL
LAGRE
The Nanalyze Verdict: Zeta Stock

The Nanalyze Verdict: Zeta Stock

Zeta Global stock is all over social media these days. You can't go on X without having the $ZETA bull thesis shoved down your throat. Today, we'll do the opposite of what all the finfluencers are doing. We're going to take an objective look at Zeta, the bull and bear case. Stay informed with our f…
00:12:42
DEL
LAGRE
How Dividend Growth Investing Allowed Buffett to Turn $14K Into $1.85M

How Dividend Growth Investing Allowed Buffett to Turn $14K Into $1.85M

My life is a product of compound interest. That's a famous quote by the great Warren Buffett, and it couldn't be more true. In this video, we'll show you how even a small amount of money can grow into a massive fortune with the power of compounding, patience, and most importantly... dividend growth…
00:08:40
DEL
LAGRE
Ansvarsfraskrivelse: Podkasten og kunstværket, det finnes indlejret på denne siden, er fra Nanalyze, som tilhører dens eier og ikke er tilknyttet eller godkjent av Listen Notes, Inc.
PROMOTED
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Audio to Text

ANBEFALINGER
Bruk API til å hente denne episode